文献速递乳房整形与再造美容整形

美容乳房手术中的患者安全举措:系统综述

Patient Safety Initiatives in Cosmetic Breast Surgery: A Systematic Review.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2022-06-28

该系统综述检索1965年至2021年发表的整形外科文献,纳入60项研究,评估美容乳房手术中患者安全与质量改进的证据。研究整体科学质量为中等,抗菌预防观点存在分歧,肿胀局部麻醉显示显著获益,引流管减少血肿和血清肿大多无获益。作者认为需要更多研究以减少感染及乳房植入物相关间变性大细胞淋巴瘤和包膜挛缩等并发症。

要点

  • 纳入60项研究,多数为回顾性研究,43.3%为第3级证据,整体科学质量为中等。
  • 抗菌预防研究占38.3%,对预防性抗生素的观点存在分歧。
  • 肿胀局部麻醉显示显著获益;引流管减少血肿和血清肿大多无获益。

核心结论

  • 患者安全与质量改进研究整体质量为中等,涉及多种干预措施。
  • 本综述发现需要额外研究以减少感染及其他乳房植入物并发症,特别是乳房植入物相关间变性大细胞淋巴瘤和包膜挛缩。

研究设计与样本

  • 遵循PRISMA指南对1965年至2021年发表的整形外科文献进行计算机化系统检索。
  • 共纳入60项研究,提取发表描述、方法学细节和总体结果。
  • 根据研究类型分别使用MINORS、Cochrane ROB2或AMSTAR 2工具评估方法学质量。

主要发现

  • 多数研究为回顾性研究,43.3%来自第3级证据。
  • 整体科学质量为中等,随机对照试验和非比较性非随机研究通常被评为更高质量。
  • 研究抗菌方法的研究占38.3%,对预防性抗生素的意见存在分歧。
  • 关注风险因素评估工具的研究占8.3%,可能在识别美容手术高风险患者方面具有实用性。
  • 评估美容乳房手术麻醉的研究占5%,显示肿胀局部麻醉具有显著获益。

关键数值与推荐

  • 抗菌预防研究占38.3%,对预防性抗生素的意见存在分歧。
  • 风险因素评估工具研究占8.3%,可能具有识别高风险患者的实用性。
  • 麻醉研究占5%,肿胀局部麻醉显示显著获益。
  • 引流管研究占8.3%,大多显示对减少血肿和血清肿无获益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多数研究为回顾性研究。
  • 43.3%的研究来自第3级证据。
  • 整体科学质量为中等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improved patient safety (PS) in cosmetic breast surgery relies upon high-quality evidence. The objective of this study was to systematically review the existing evidence for PS and quality improvement (QI) in cosmetic breast surgery. METHODS: A systematic review of published plastic surgery literature from 1965 to 2021 was undertaken through a computerized search following PRISMA guidelines. Publication descriptors, methodological details, and overall results were extracted. Articles were assessed for methodological quality using either the MINORS, Cochrane ROB2, or AMSTAR 2 instrument depending on the type of study. RESULTS: Sixty studies were included. Most studies were retrospective, and 43.3 percent were from the 3rd level of evidence. Overall, the scientific quality was moderate, with randomized controlled trials and non-comparative non-randomized studies generally being rated of higher quality. Studies investigating approaches to antisepsis (38.3 percent) in cosmetic breast surgery indicated conflicting opinions on prophylactic antibiotics. Studies focusing on risk factor assessment tools (8.3 percent) held possible utility in identifying high-risk patients for cosmetic surgery. Studies assessing anesthesia in cosmetic breast surgery (5 percent) demonstrated a significant benefit to tumescent local anesthesia. Drains for decreasing hematoma and seroma (8.3 percent) largely showed no benefit. CONCLUSIONS: Overall, PS and QI studies were of moderate quality and investigated numerous interventions. Our review identified a need for additional studies to decrease infection and other breast implant morbidities, specifically breast implant-associated anaplastic large cell lymphoma and capsular contracture.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Prabhu N, McGuire C, Hong P, et al. Patient Safety Initiatives in Cosmetic Breast Surgery: A Systematic Review. J Plast Reconstr Aesthet Surg. 2022. PMID: 36123255. doi:10.1016/j.bjps.2022.06.099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。